Role of opioids in acute and delayed preconditioning.
A number of endogenous mediators, including opioids, adenosine and bradykinin, which act on cardiac cell membrane receptors have been demonstrated to trigger the phenomenon termed ischemic preconditioning (IPC). IPC is an endogenous protective mechanism, whereby a brief period of ischemia or hypoxia protects a cell or organ, in this review the heart, against injury from a subsequent more prolonged stressful insult. Recent data suggest that opioid receptors are important triggers and/or mediators of this protective response. Selective pharmacological antagonists of the delta-or kappa-opioid receptor have been shown to block IPC, and agonists of these same receptors have been shown to mimic IPC in intact animals, isolated hearts or isolated cardiomyocytes. This review will summarize the current state of knowledge, which exists defining the role and cellular signaling pathways by which endogenously or exogenously administered opioids produce their cardioprotective response. The potential clinical application and evidence to suggest that opioids produce a similar protective effect in man will also be discussed.
Gross
Garrett J
GJ
Department of Pharmacology and Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226-3548, USA. ggross@post.its.mcw.edu
D000818:Animals; D003451:Cryoprotective Agents; D006801:Humans; D019157:Ischemic Preconditioning, Myocardial; D009294:Narcotics / Q000819:agonists / Q000378:metabolism*; D017465:Receptors, Opioid, delta; D017473:Receptors, Opioid, kappa; D015398:Signal Transduction
D003451:Cryoprotective Agents; D009294:Narcotics; D017465:Receptors, Opioid, delta; D017473:Receptors, Opioid, kappa